Comparing the Efficacy Between Lignocaine Given Via MADgic Atomizer and Lignocaine Pump Spray
NCT ID: NCT06213116
Last Updated: 2024-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
125 participants
INTERVENTIONAL
2021-12-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy
NCT03109392
Impact of Covid-19 Aerosol Box On Intubation Success Rate
NCT06042829
Application of Electrically Driven Atomized Surface Anesthesia in ATI in Patients With Predictably Difficult Airway.
NCT06420947
Comparing Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™
NCT03130413
Comparison of the GMA-TULIP and I-gel Laryngeal Mask for Airway Management in General Anaesthesia: a Randomized Controlled Trial
NCT07019961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MADgic Atomizer
Group M(MADgic) acting as Intervention Group:
Patients receiving Lignocaine 30mg (3 alliquotes) given via MADgic Laryngotracheal Atomization Device prior to endotracheal intubation.
MADgic Atomizer
Device to deliver directly lignocaine
Lignocaine Spray
Group S (Spray) acting as Control Group:
Patients receiving Lignocaine 30 mg (3 puffs) given via 10mg Lignocain Pump Spray prior to endotracheal intubation.
Lignocaine pump spray
Lignocaine 30 mg (3 puffs) given via 10mg Lignocaine Pump Spray prior to endotracheal intubation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MADgic Atomizer
Device to deliver directly lignocaine
Lignocaine pump spray
Lignocaine 30 mg (3 puffs) given via 10mg Lignocaine Pump Spray prior to endotracheal intubation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender of both male and female
* Planned for elective surgery scheduled at General Operation Theatre that require elective intubation for general anesthesia
* American Society Anaesthesiologist (ASA) preoperative physical status assessment of 1 and 2
* Airway assessment Malampati scoring 1and 2.
Exclusion Criteria
* Known allergy or hypersensitivity to Lignocaine
* Pre existing sore throat or hoarseness of voice identified during preoperative assessment.
* The use of airway device other than endotracheal tube (ETT) such Laryngeal Mask airway/Supraglottic Device'
* Oral and neck surgery
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Sains Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rhendra Hardy Mohamad Zaini
Asssociate Proffessor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
rhendra hardy Mohamad Zaini, MD
Role: PRINCIPAL_INVESTIGATOR
Universiti Sains Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Science Malaysia Hospital
Kubang Kerian, Kelantan, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USM/JEPeM/21080580
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.